Modified Allergens for Immunotherapy

Authors:

Abstract
During the past few decades, modified allergens have been developed for use in allergen-specific immunotherapy (AIT) with the aim to improve efficacy and reduce adverse effects. This review aims to provide an overview of the different types of modified allergens, their mechanism of action and their potential for improving AIT.
Funding Information
  • Swiss National Science Foundation (320030–159870)

This publication has 121 references indexed in Scilit: